BIODESIGN DURAL GRAFT
Report
- Report Number
- 1835959-2019-00002
- Event Type
- Injury
- Date Received
- May 15, 2019
- Date of Event
- April 22, 2019
- Report Date
- May 15, 2019
- Manufacturer
- COOK BIOTECH
- Product Code
- GXQ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KR
- Reporter Occupation
- PHYSICIAN
Narratives
LOT #: LOT NUMBER NOT PROVIDED BY THE COMPLAINANT. EXPIRATION DATE: PRODUCT EXPIRE DATE UNKNOWN; LOT NUMBER NOT PROVIDED. CATALOG #: PRODUCT CATALOG NUMBER UNKNOWN, PRODUCT UNSPECIFIED. PMA/510K: K160869. MANUFACTURE DATE: PRODUCT MANUFACTURE DATE UNKNOWN; LOT NUMBER NOT PROVIDED. DEVICE LOT HISTORY RECORDS WERE NOT ABLE TO REVIEWED DUE TO THE COMPLAINANT NOT REPORTING THE LOT NUMBER. THE DEVICE RPN WAS ALSO NOT REPORTED. HOWEVER, THE PROCEDURE WAS A SKULL BASE PROCEDURE AND THE BIODESIGN DURAL GRAFT IS SOLD IN KOREA. THE COMPLAINANT ALSO MENTIONED THE DEVICE WAS A 4-LAYER DEVICE; AS IS THE DURAL GRAFT. PRESUMABLY A BIODESIGN DURAL GRAFT WAS USED IN THIS CASE. THE IFU LISTS CSF LEAK AMONGST THE POTENTIAL COMPLICATIONS. THE ROOT CAUSE, OF THE HOLE IN THE GRAFT, IS INCONCLUSIVE. HOWEVER, BASED ON A REVIEW OF THE PHOTOS PROVIDED BY THE COMPLAINANT, THE HOLE DID NOT APPEAR TO BE DUE TO DEGRADATION OF THE GRAFT. THE HOLE APPEARED TO BE THE RESULT OF CUTTING OR PUNCTURING. IT IS POSSIBLE THAT THE HOLE WAS THE RESULT OF A DRAINAGE CATHETER OR UNINTENTIONAL CUTTING OF THE GRAFT DURING PLACEMENT OR REOPERATION. THE CSF LEAK IS A KNOWN POTENTIAL COMPLICATION OF THE SURGICAL PROCEDURE.
DR. (B)(6) IMPLANTED A BIODESIGN DURAL GRAFT, ON (B)(6) 2019, FOR A SKULL BASE SURGERY FOR A BRAIN TUMOR. THE GRAFT WAS HYDRATED PRIOR TO PLACEMENT. A DRAINAGE CATHETER WAS PLACED, BUT THE SURGEON COULD NOT RECALL THE LOCATION OF PLACEMENT. THE PATIENT THEN PRESENTED WITH A CSF (CEREBROSPINAL FLUID) LEAK. DR. (B)(6) REOPERATED, ON (B)(6) 2019, AND FOUND THERE WAS A HOLE IN THE MIDDLE OF THE BIODESIGN PRODUCT. THE CSF WAS LEAKING FROM THE HOLE. A COMPETITOR'S PRODUCT WAS SUTURED TO THE HOLE IN THE BIODESIGN. ON (B)(6) 2019, DR. (B)(6) (WITH (B)(6)) INDICATED THE PATIENT WAS IN THE HOSPITAL AND WAS NOT HAVING ANY PROBLEMS. THE ADDITIONAL GRAFT ADDED TO THE BIODESIGN STOPPED THE CSF LEAK. DR. (B)(6) INDICATED HE HAD NOT SEEN THIS IN 10 YEARS OF BIODESIGN EXPERIENCE. HOWEVER, DEPENDING ON THE PATIENT, THE RATE OF REMODELING VARIES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 407198 | BIODESIGN DURAL GRAFT | DURAL GRAFT | GXQ | COOK BIOTECH | UNKNOWN | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 17 YR | Required Intervention | A DRAINAGE CATHETER WAS PLACED. |